Location: Chicago, IL
CIK: 0000314957 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Oct 16, 2024
Total Value: $118M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BND | VANGUARD BD INDEX FDS TOTAL BND MRKT | 552,830 | $41.52M | 35.1% | — | — | TOTAL BND MRKT | 921937835 |
| VT | VANGUARD INTL EQUITY INDEX F | 335,471 | $40.16M | 34.0% | — | — | TT WRLD ST ETF | 922042742 |
| VOO | VANGUARD INDEX FDS | 68,413 | $36.21M | 30.6% | — | — | S&P 500 ETF SHS | 922908363 |
| NKGN | NKGEN BIOTECH INC | 550,000 | $208K | 0.2% | — | — | COM | 65488A101 |
| PYXS | PYXIS ONCOLOGY INC | 48,731 | $179K | 0.2% | — | — | COMMON STOCK | 747324101 |